Cruijsen, Marjan <br/><br/>
Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  06 2016 
 - 1000-1008 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2016.02.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Neoplasm--immunology<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Azacitidine--administration & dosage<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Decitabine<br/>Female<br/>Graft vs Host Disease<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Leukemia, Myeloid, Acute--mortality<br/>Leukemia, Myelomonocytic, Chronic--mortality<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--mortality<br/>Survival Analysis<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Homologous<br/>Vidarabine--administration & dosage<br/>Whole-Body Irradiation